-
1
-
-
8944249286
-
Timed-sequential induction therapy improves post remission outcome in acute myeloid leukemia: A report from the Children's Cancer Group
-
Woods WG, Kobrinsky N, Buckley JD et al. Timed-sequential induction therapy improves post remission outcome in acute myeloid leukemia: a report from the Children's Cancer Group. Blood 1996; 87: 4979-4989.
-
(1996)
Blood
, vol.87
, pp. 4979-4989
-
-
Woods, W.G.1
Kobrinsky, N.2
Buckley, J.D.3
-
2
-
-
0028109796
-
Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission
-
Barrett AJ, Horowitz MM, Pollock BH et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. New Engl J Med 1994; 331: 1253-1258.
-
(1994)
New Engl. J. Med.
, vol.331
, pp. 1253-1258
-
-
Barrett, A.J.1
Horowitz, M.M.2
Pollock, B.H.3
-
3
-
-
20244384398
-
Unrelated donor marrow transplantation in children
-
Balduzzi A, Gooley T, Anasetti C et al. Unrelated donor marrow transplantation in children. Blood 1995; 86: 3247-3256.
-
(1995)
Blood
, vol.86
, pp. 3247-3256
-
-
Balduzzi, A.1
Gooley, T.2
Anasetti, C.3
-
4
-
-
0032544083
-
T cells recognizing leukemic CD34+ progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation
-
Smith WM, Rijnbeek M, van Bergen CAM et al. T cells recognizing leukemic CD34+ progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation. Proc Natl Acad Sci USA 1998; 95: 10152-10157.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 10152-10157
-
-
Smith, W.M.1
Rijnbeek, M.2
van Bergen, C.A.M.3
-
5
-
-
17744419349
-
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia
-
Passweg JR, Tiberghien P, Cahn J-Y et al. Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia. Bone Marrow Transplant 1998; 21: 153-158.
-
(1998)
Bone Marrow Transplant.
, vol.21
, pp. 153-158
-
-
Passweg, J.R.1
Tiberghien, P.2
Cahn, J.-Y.3
-
6
-
-
0033566880
-
Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes
-
Falkenburg JH, Wafelman AR, Joosten P et al. Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes. Blood 1999; 94: 1201-1208.
-
(1999)
Blood
, vol.94
, pp. 1201-1208
-
-
Falkenburg, J.H.1
Wafelman, A.R.2
Joosten, P.3
-
7
-
-
0032558759
-
Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype
-
Aversa F, Tabilio A, Velardi A et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. New Engl J Med 1998; 339: 1186-1193.
-
(1998)
New Engl. J. Med.
, vol.339
, pp. 1186-1193
-
-
Aversa, F.1
Tabilio, A.2
Velardi, A.3
-
8
-
-
0030965273
-
Use of partially mismatched related donors extends access to allogeneic marrow transplant
-
Henslee-Downey PJ, Abhyankar SH, Parrish RS et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood 1997; 89: 3864-3872.
-
(1997)
Blood
, vol.89
, pp. 3864-3872
-
-
Henslee-Downey, P.J.1
Abhyankar, S.H.2
Parrish, R.S.3
-
9
-
-
0033041839
-
Transplantation of megadoses of purified haploidentical stem cells
-
discussion 361-362
-
Handgretinger R, Schumm M, Lang P et al. Transplantation of megadoses of purified haploidentical stem cells. Ann NY Acad Sci 1999; 872: 351-361; discussion 361-362.
-
(1999)
Ann. NY Acad. Sci.
, vol.872
, pp. 351-361
-
-
Handgretinger, R.1
Schumm, M.2
Lang, P.3
-
10
-
-
0032715342
-
+ cells from HLA-mismatched parental donors in 14 children: Evaluation of early monitoring of engraftment
-
+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment. Leukemia 1999; 13: 2070-2078.
-
(1999)
Leukemia
, vol.13
, pp. 2070-2078
-
-
Peters, C.1
Matthes-Martin, S.2
Fritsch, G.3
-
11
-
-
0032616043
-
Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets
-
Johnson BD, Becker EE, Truitt RL. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets. Biol Blood Marrow Transplant 1999; 5: 123-132.
-
(1999)
Biol. Blood Marrow Transplant.
, vol.5
, pp. 123-132
-
-
Johnson, B.D.1
Becker, E.E.2
Truitt, R.L.3
-
12
-
-
0026730058
-
Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia
-
Faber LM, van Luxemburg-Heijs SA, Willemze R, Falkenburg JH. Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia. J Exp Med 1992; 176: 1283-1289.
-
(1992)
J. Exp. Med.
, vol.176
, pp. 1283-1289
-
-
Faber, L.M.1
van Luxemburg-Heijs, S.A.2
Willemze, R.3
Falkenburg, J.H.4
-
13
-
-
0014251127
-
Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs
-
Brunner KT, Mauel J, Cerottini JC, Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 1968; 14: 181-196.
-
(1968)
Immunology
, vol.14
, pp. 181-196
-
-
Brunner, K.T.1
Mauel, J.2
Cerottini, J.C.3
Chapuis, B.4
-
14
-
-
0032464405
-
Expression patterns of costimulatory molecules on cells derived from human hematological malignancies
-
Zheng Z, Takahashi M, Aoki S et al. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies. J Exp Clin Cancer Res 1998; 17: 251-258.
-
(1998)
J. Exp. Clin. Cancer Res.
, vol.17
, pp. 251-258
-
-
Zheng, Z.1
Takahashi, M.2
Aoki, S.3
-
15
-
-
0030989818
-
CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules
-
Van den Hove LE, Van Gool SW, Vandenberghe P et al. CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules. Leukemia 1997; 11: 572-580.
-
(1997)
Leukemia
, vol.11
, pp. 572-580
-
-
Van den Hove, L.E.1
Van Gool, S.W.2
Vandenberghe, P.3
-
16
-
-
8944238969
-
Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen
-
Cardoso AA, Schultze JL, Boussiotis VA et al. Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen. Blood. 1996; 88: 41-48.
-
(1996)
Blood
, vol.88
, pp. 41-48
-
-
Cardoso, A.A.1
Schultze, J.L.2
Boussiotis, V.A.3
-
17
-
-
0032735040
-
CD40 cross-linking enhances the immunogenicity of Burkitt's lymphoma cell lines
-
Frisan T, Donati D, Cervenak L et al. CD40 cross-linking enhances the immunogenicity of Burkitt's lymphoma cell lines. Int J Cancer 1999; 83: 772-779.
-
(1999)
Int. J. Cancer
, vol.83
, pp. 772-779
-
-
Frisan, T.1
Donati, D.2
Cervenak, L.3
-
18
-
-
0028593449
-
Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors
-
Chouaib S, Chehimi J, Bani L et al. Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors. Proc Natl Acad Sci USA 1994; 91: 12659-12663.
-
(1994)
Proc. Natl. Acad. Sci. USA
, vol.91
, pp. 12659-12663
-
-
Chouaib, S.1
Chehimi, J.2
Bani, L.3
-
19
-
-
0024467154
-
Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes
-
Kobayashi M, Fitz L, Ryan M et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989; 170: 827-845.
-
(1989)
J. Exp. Med.
, vol.170
, pp. 827-845
-
-
Kobayashi, M.1
Fitz, L.2
Ryan, M.3
-
20
-
-
0035353187
-
Differential use of Fas ligand and perform cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect
-
Schmaltz C, Alpdogan O, Horndasch KJ et al. Differential use of Fas ligand and perform cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect. Blood 2000; 97: 2886-2895.
-
(2000)
Blood
, vol.97
, pp. 2886-2895
-
-
Schmaltz, C.1
Alpdogan, O.2
Horndasch, K.J.3
-
21
-
-
0033230957
-
Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease
-
Waller EK, Ship AM, Mittelstaedt S et al. Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease. Blood 1999; 94: 3222-3233.
-
(1999)
Blood
, vol.94
, pp. 3222-3233
-
-
Waller, E.K.1
Ship, A.M.2
Mittelstaedt, S.3
-
22
-
-
0030472309
-
Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease
-
Fowler DH, Breglio J, Nagel G et al. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease. J Immunol 1996; 157: 4811-4821.
-
(1996)
J. Immunol.
, vol.157
, pp. 4811-4821
-
-
Fowler, D.H.1
Breglio, J.2
Nagel, G.3
-
23
-
-
0011992563
-
GVHD as a Th1-type process: Regulation by cells of Th2 cytokine phenotype
-
Burakoff S, Deeg HJ, Ferrara J, Atkinson K (eds). 2nd edn. Marcel Decker Inc: New York
-
Fowler DH, Gress RE. GVHD as a Th1-type process: Regulation by cells of Th2 cytokine phenotype. In: Burakoff S, Deeg HJ, Ferrara J, Atkinson K (eds). Graft-vs-Host Disease: Immunology, Pathophysiology, and Treatment, 2nd edn. Marcel Decker Inc: New York, pp 479-500.
-
Graft-vs-Host Disease: Immunology, Pathophysiology, and Treatment
, pp. 479-500
-
-
Fowler, D.H.1
Gress, R.E.2
-
24
-
-
4244124955
-
Allogeneic lymphocytes can mediate graft-versus-leukemia without causing graft-versus-host disease
-
Boyer MW, Johnson TS, Yeager AM et al. Allogeneic lymphocytes can mediate graft-versus-leukemia without causing graft-versus-host disease. Blood 1996; 88: 244a.
-
(1996)
Blood
, vol.88
-
-
Boyer, M.W.1
Johnson, T.S.2
Yeager, A.M.3
-
25
-
-
0032100450
-
Prevention of marrow graft rejection without induction of graft-versus-host disease by a cytotoxic T-cell clone that recognizes recipient alloantigens
-
Kusunoki Y, Chen W, Martin PJ. Prevention of marrow graft rejection without induction of graft-versus-host disease by a cytotoxic T-cell clone that recognizes recipient alloantigens. Blood 1998; 91: 4038-4044.
-
(1998)
Blood
, vol.91
, pp. 4038-4044
-
-
Kusunoki, Y.1
Chen, W.2
Martin, P.J.3
-
26
-
-
0033554726
-
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
-
Sallusto F, Lenig D, Forster R et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708-712.
-
(1999)
Nature
, vol.401
, pp. 708-712
-
-
Sallusto, F.1
Lenig, D.2
Forster, R.3
-
27
-
-
0028114542
-
Prevention of T cell anergy by signalling through the γc chain of the IL-2 receptor
-
Boussiotis VA, Barber DL, Nakarai T et al. Prevention of T cell anergy by signalling through the γc chain of the IL-2 receptor. Science 1994; 266: 1039-1042.
-
(1994)
Science
, vol.266
, pp. 1039-1042
-
-
Boussiotis, V.A.1
Barber, D.L.2
Nakarai, T.3
-
28
-
-
0033564639
-
Human vascular endothelial cells favor clonal expansion of unusual alloreactive CTL
-
Biedermann BC, Pober JS. Human vascular endothelial cells favor clonal expansion of unusual alloreactive CTL. J Immunol 1999; 162: 7022-7030.
-
(1999)
J. Immunol.
, vol.162
, pp. 7022-7030
-
-
Biedermann, B.C.1
Pober, J.S.2
-
29
-
-
0034609968
-
T-cell function and migration. Two sides of the same coin
-
Andrian UH, Mackay CR. T-cell function and migration. Two sides of the same coin. New Engl J Med 2000; 343: 1020-1034.
-
(2000)
New Engl. J. Med.
, vol.343
, pp. 1020-1034
-
-
Andrian, U.H.1
Mackay, C.R.2
-
30
-
-
0022000635
-
The in vivo behavior of T cell clones: Altered migration due to loss of the lymphocyte surface homing receptor
-
Dailey MO, Gallatin WM, Weissman IL. The in vivo behavior of T cell clones: altered migration due to loss of the lymphocyte surface homing receptor. J Mol Cell Immunol 1985; 2: 27-36.
-
(1985)
J. Mol. Cell Immunol.
, vol.2
, pp. 27-36
-
-
Dailey, M.O.1
Gallatin, W.M.2
Weissman, I.L.3
-
31
-
-
0035101377
-
Blocking L-selectin and α4-integrin changes donor cell homing pattern and ameliorates murine acute graft versus host disease
-
Li B, New JY, Yap EH et al. Blocking L-selectin and α4-integrin changes donor cell homing pattern and ameliorates murine acute graft versus host disease. Eur J Immunol 2001; 31: 617-624.
-
(2001)
Eur. J. Immunol.
, vol.31
, pp. 617-624
-
-
Li, B.1
New, J.Y.2
Yap, E.H.3
|